Cambridge, MA, United States of America

James B Hemphill

USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: James B Hemphill: Innovator in Genome Editing Technology

Introduction

James B Hemphill is a prominent inventor based in Cambridge, MA (US). He is known for his groundbreaking work in the field of genome editing, particularly through the development of innovative CRISPR/Cas9 technologies. His contributions have significantly advanced the capabilities of genetic manipulation.

Latest Patents

Hemphill holds a patent for an "Activatable CRISPR/CAS9 for spatial and temporal control of genome editing." This invention discloses a genetically encoded light- or chemically-activated Cas9, engineered through the site-specific installation of an activatable lysine amino acid. The activatable Cas9 proteins can be utilized in CRISPR/Cas9 systems to control gene expression both temporally and spatially. The patent also provides systems, methods, kits, and compositions for manipulating sequences and/or activities of target sequences. Additionally, it includes methods for directing CRISPR complex formation in cells and selecting specific cells by introducing precise mutations using the CRISPR/Cas9 system. Hemphill's innovative approach has the potential to revolutionize genetic research and applications.

Career Highlights

Throughout his career, Hemphill has worked with esteemed institutions such as the University of Pittsburgh and the University of North Carolina at Chapel Hill. His experience in these research environments has allowed him to collaborate with leading scientists and contribute to significant advancements in genetic engineering.

Collaborations

Some of Hemphill's notable coworkers include Alexander Deiters and Aravind Asokan. Their collaborative efforts have further enhanced the research and development of CRISPR technologies.

Conclusion

James B Hemphill's contributions to the field of genome editing through his innovative patent and collaborative work have established him as a key figure in genetic research. His advancements in CRISPR technology continue to pave the way for future innovations in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…